Article Details

CASI Pharmaceuticals (CASI) Downgraded by BidaskClub to Buy

Retrieved on: 2018-02-15 00:18:45

Tags for this article:

Click the tags to see associated articles and topics

CASI Pharmaceuticals (CASI) Downgraded by BidaskClub to Buy. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC boosted its holdings in CASI Pharmaceuticals by 33.4% during the fourth quarter. <b>Renaissance Technologies</b> LLC now owns 150,600 shares of the biotechnology company's stock worth $489,000 after buying an additional 37,700 shares in the last quarter. Geode Capital ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo